Accessed 4 May 2021
The more common adverse effects include allergic reactions, stomach pain, diarrhea, constipation, nausea, and vomiting
Future studies should analyze the dermatologic side effects of these medications as consumers share concerns regarding their impact on the skin, the study authors conclude.
Compared to other weight loss drugs, using GLP-1 agonists increases the risk of pancreatitis (inflammation of the pancreas) by 9 times, bowel obstruction (blockage of the small or large intestines) by 4.5 times, and gastroparesis (a condition that slows or stops the movement of food from the stomach to the small intestine) by 3.6 times
Reducing from 1 mg to 0.5 mg, or from 2 mg to 1 mg, is a perfectly valid approach
Kingdoms weight loss treatments may be appropriate for individuals who struggle with appetite regulation, metabolic resistance, or weight loss despite prior efforts